全文获取类型
收费全文 | 50392篇 |
免费 | 3770篇 |
国内免费 | 1430篇 |
专业分类
耳鼻咽喉 | 355篇 |
儿科学 | 590篇 |
妇产科学 | 562篇 |
基础医学 | 2831篇 |
口腔科学 | 788篇 |
临床医学 | 4149篇 |
内科学 | 7091篇 |
皮肤病学 | 588篇 |
神经病学 | 4154篇 |
特种医学 | 943篇 |
外国民族医学 | 2篇 |
外科学 | 3003篇 |
综合类 | 5856篇 |
现状与发展 | 1篇 |
一般理论 | 8篇 |
预防医学 | 5816篇 |
眼科学 | 744篇 |
药学 | 11744篇 |
36篇 | |
中国医学 | 4408篇 |
肿瘤学 | 1923篇 |
出版年
2024年 | 120篇 |
2023年 | 998篇 |
2022年 | 1779篇 |
2021年 | 2625篇 |
2020年 | 2696篇 |
2019年 | 3197篇 |
2018年 | 3011篇 |
2017年 | 2663篇 |
2016年 | 2147篇 |
2015年 | 1750篇 |
2014年 | 3319篇 |
2013年 | 4945篇 |
2012年 | 3651篇 |
2011年 | 2839篇 |
2010年 | 2276篇 |
2009年 | 1834篇 |
2008年 | 1714篇 |
2007年 | 1787篇 |
2006年 | 1456篇 |
2005年 | 1319篇 |
2004年 | 1091篇 |
2003年 | 1090篇 |
2002年 | 786篇 |
2001年 | 719篇 |
2000年 | 605篇 |
1999年 | 517篇 |
1998年 | 379篇 |
1997年 | 382篇 |
1996年 | 398篇 |
1995年 | 315篇 |
1994年 | 255篇 |
1993年 | 277篇 |
1992年 | 263篇 |
1991年 | 200篇 |
1990年 | 179篇 |
1989年 | 149篇 |
1988年 | 165篇 |
1987年 | 111篇 |
1986年 | 122篇 |
1985年 | 227篇 |
1984年 | 191篇 |
1983年 | 144篇 |
1982年 | 157篇 |
1981年 | 112篇 |
1980年 | 108篇 |
1979年 | 92篇 |
1978年 | 89篇 |
1977年 | 71篇 |
1976年 | 62篇 |
1975年 | 62篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
Carl J O'Kane Douglas C Tutt Lyndon A Bauer 《Emergency medicine Australasia : EMA》2002,14(3):296-303
Cannabis and driving is an emerging injury‐prevention concern. The incidence of driving while affected by cannabis is rising in parallel with increased cannabis use in the community. Younger drivers are at particular risk. Improvements in research methodology, technology and laboratory testing methods have occurred in the last 10 years. These cast doubt on earlier results and conclusions. Studies now show that cannabis has a significant impairing effect on driving when used alone and that this effect is exaggerated when combined with alcohol. Of particular concern is the presence of cannabis as the sole psychoactive drug in an increasing number of road fatalities and the lack of any structural response to this problem. A review of testing methods, laboratory and real driving studies, and recent epidemiological studies is presented. Suggestions for methods of further data collection and future public policy are made. 相似文献
93.
基于医疗伦理观的医疗质量成本计量与决策分析 总被引:4,自引:1,他引:3
医疗质量成本是建立在医疗伦理基础上的决策过程中或医疗服务决策时所必须考虑的一个重要因素。基于医疗伦理观的医疗信誉成本的正确计量及决策分析是医疗卫生机构提升医疗服务价值的关键所在。 相似文献
94.
目的 了解肿瘤住院患者使用免疫调节药的现状,为临床合理用药提供参考。方法对2003~2005年免疫调节药应用情况运用药物使用频度(DDDs)、年均增率(AARG)等分析方法,进行统计分析。结果 免疫调节药销售金额年均增长率达106.69%。生物反应修饰剂销售金额占总金额的65.93%。生物反应修饰剂和增强免疫功能中成药用药频度相当。排序靠前的是金黄色葡萄球菌滤液注射液、参芪扶正注射液,用量上升最快的是香菇多糖注射液、胸腺素α1注射液。结论 免疫调节药是肿瘤放化疗必备用药,在肿瘤患者住院治疗中应用广泛。整体上该类药物的应用基本合理。疗效显著且作用广泛的药物成为临床首选。 相似文献
95.
The toxic effects of nitroquine-dapsone compound(NQD)in mice and dogs were studied.The therapeutic index of NQDin mice is 1911,the greatest among the 6 antimalarials tested.Thetoxic effects of NQD(50 mg/kg/day for 3 days per os)and nitro-quine in dogs were manifested by injuries on the adrenal cortexand intestinal epithelium.When folic acid(4 mg/kg/day for 4 days)or calcium leucovorinum(0.3 mg/kg/day for 4 days)were usedconcomitantly with NQD,the death rate and the incidence of dia-rrhea in the toxicated dogs were greatly reduced,the injury on theintestinal epithelium was much milder,and the goblet cells weremuch more numerous than those without treatment.The results suggestthat folic acid and calcium leucovorinum can protect the undifferen-tiated cells in the intestinal crypts from being injured by NQD. 相似文献
96.
李松林副主任医师将肾小球肾炎的病机概括为湿、热、毒、瘀、虚等方面,在中医辨证的基础上,结合现代医学对其病因和发病机理的认识及中草药药理作用,针对不同的病理机制和临床表现,提出清热解毒法,活血化瘀法,调补脾肾法,扶正固本法,并视症有机结合,恰当治疗,疗效显著。 相似文献
97.
Diseases like rotavirus afflict both upper- and lower-income countries, but most serious illnesses and deaths occur among the latter. It is a vital public health issue that vaccines for these types of global diseases can recover research and development (R&D) costs from high-priced markets quickly so that manufacturers can offer affordable prices to lower-income nations. Cost recovery depends on how high R&D costs are, and this study attempts to replace high, unverified estimates with lower, more verifiable estimates for two new vaccines, RotaTeq (Merck) and Rotarix (GlaxoSmithKline or GSK), based on detailed searches of public information and follow-up interviews with senior informants. We also offer a new perspective on “cost of capital” as a claim for recovery from public bodies. Our estimates suggest that companies can recover all fixed costs quickly from affluent markets and thus can offer these vaccines to lower-income countries at prices they can afford. Better vaccines are a shared project between companies and public health agencies; greater transparency and consistency in reporting of R&D costs is needed so that fair prices can be established. 相似文献
98.
99.
周新国 《南通大学学报(哲学社会科学版)》2003,19(3):24-28
张謇的教育思想十分丰富 ,并且具有鲜明的时代特点。他在江苏南通的教育实践成就卓著 ,极富特色。他较早地提出了教育为地方经济社会发展服务的思想 ,创造了“以实业辅助教育 ,以教育促进实业”的成功模式 ,反映了教育从边缘走向经济中心这一历史发展的趋势。张謇的教育思想与实践在近代中国教育史上有重要地位 相似文献
100.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献